Evidence map›Paper›PMID 17240116›Full record

ArticleCellular signalling2007

Differential FAK phosphorylation at Ser-910, Ser-843 and Tyr-397 induced by angiotensin II, LPA and EGF in intestinal epithelial cells.

Xiaohua Jiang, James Sinnett-Smith, Enrique Rozengurt

Abstract read
In one paragraph

Article in Cellular signalling, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Rapid protein kinase D1 signaling promotes migration of intestinal epithelial cells.American journal of physiology. Gastrointestinal and liver physiology · 2012
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. GABAB receptor activation protects neurons from apoptosis via IGF-1 receptor transactivation.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2010
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Xiaohua JiangDivision of Digestive Diseases, Department of Medicine, David Geffen School of Medicine, CURE: Digestive Diseases Research Center and Molecular Biology Institute, University of California, Los Angeles, California 90095-178622, USA.
James Sinnett-Smith
Enrique Rozengurt
Human BioMolecular Research Institute · US

Funding

Pilot and Feasibility ProgramP30DK041301 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ROZENGURT, JUAN ENRIQUE · 1990 to 2019
$18.0M
UCLA SPORE IN LUNG CANCERP50CA090388 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI DUBINETT, STEVEN M. · 2001 to 2008
$13.0M
TUMOR CELL SURFACES AND CHROMOSOMEST32CA009056 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Gay M Crooks, David A. Nathanson · 1985 to 2026
$10.5M
GASTROINTESTINAL PEPTIDE SIGNALING THROUGH PKC/PKDR01DK055003 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ROZENGURT, JUAN ENRIQUE · 1999 to 2011
$4.9M
GI PEPTIDE SIGNALING THROUGH TYROSINE PHOSPHORYLATIONR01DK056930 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ROZENGURT, JUAN ENRIQUE · 2000 to 2010
$3.0M
NCI NIH HHS P50 CA090388NCI NIH HHS P50 CA90388NCI NIH HHS T32 CA009056NIDDK NIH HHS DK 55003NIDDK NIH HHS DK 56930NIDDK NIH HHS P30 DK041301NIDDK NIH HHS P30 DK41301NIDDK NIH HHS R01 DK055003NIDDK NIH HHS R01 DK056930
6 · The paper itself

Abstract

A rapid increase in the tyrosine phosphorylation of the non-receptor tyrosine kinase FAK is a prominent early event in fibroblasts stimulated by a variety of signaling molecules. However, a variety of epithelial cells, including intestinal epithelial cells, show a high basal level of tyrosine phosphorylated FAK that is only slightly further increased by addition of G protein-coupled receptor (GPCR) agonists or growth factors. In this study, we determined whether these stimuli could elicit FAK phosphorylation at serine residues, including Ser-910 and Ser-843. Our results show that multiple agonists including angiotensin II (ANGII), lysophosphatidic acid (LPA), phorbol esters and EGF induced a striking stimulation of FAK phosphorylation at Ser-910 in rat intestinal epithelial IEC-18 cells via an ERK-dependent pathway. In striking contrast, none of these stimuli promoted a significant further increase in FAK phosphorylation at Tyr-397 in these cells. These results were extended using cultures of polarized human colonic epithelial T84 cells. We found that either carbachol or EGF promoted a striking ERK-dependent phosphorylation of FAK at Ser-910, but these agonists caused only slight stimulation of FAK at Tyr-397 in T84 cells. In addition, we demonstrated that GPCR agonists also induced a dramatic increase of FAK phosphorylation at Ser-843 in either IEC-18 or T84 cells. Our results indicate that Ser-910 and Ser-843, rather than Tyr-397, are prominent sites differentially phosphorylated in response to neurotransmitters, bioactive lipids, tumor promoters and growth factors in intestinal epithelial cells.

Indexed as

AngiotensinsAnimalsCarbacholCell LineEpidermal Growth FactorExtracellular Signal-Regulated MAP KinasesFocal Adhesion Protein-Tyrosine KinasesHumansIntestinal MucosaIonomycinKineticsLysophospholipidsPhosphorylationProtein Kinase CRatsReceptors, G-Protein-CoupledAngiotensinsCarbacholEpidermal Growth FactorExtracellular Signal-Regulated MAP KinasesFocal Adhesion Protein-Tyrosine KinasesIonomycinlysophosphatidic acidLysophospholipidsProtein Kinase CReceptors, G-Protein-CoupledSerineTyrosine

Identifiers

PMID17240116
PMCPMC1868572
OpenAlexW2032546705

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.